Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
Human Molecular Genetics|February 5, 2019
Titin truncations lead to impaired cardiomyocyte autophagy and mitochondrial function in vivoJin Zhou, Benjamin Ng, Nicole S J Ko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 8, 2018
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single centerFrancesco Mazzarotto, Francesca Girolami, Beatrice Boschi, et al.
Circulation|June 24, 2021
Dysregulated Phenylalanine Catabolism Plays a Key Role in the Trajectory of Cardiac AgingGabor Czibik, Zaineb Mezdari, Dogus Murat Altintas, et al.
European Heart Journal. Cardiovascular Imaging|March 22, 2025
Changes in Coronary Disease Management Decisions in Real World Practice between 2015 and 2023: Insights from the Evarest/BSE-NSTEP observational studyCasey L Johnson, Samuel Krasner, William Woodward, et al.
European Heart Journal Open|October 26, 2022
Left ventricular assessment with artificial intelligence increases the diagnostic accuracy of stress echocardiographyJamie M O'Driscoll, William Hawkes, Arian Beqiri, et al.
The Journal of Clinical Investigation|June 25, 2014
RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processingHenrike Maatz, Marvin Jens, Martin Liss, et al.
Echo Research and Practice|October 10, 2025
Contemporary review of stress echocardiography workforce within the UK: an EVAREST/BSE NSTEP studyJames Willis, Casey L Johnson, Samuel Krasner, et al.
Radiology|June 6, 2018
Fractal Analysis of Right Ventricular Trabeculae in Pulmonary HypertensionTimothy J W Dawes, Jiashen Cai, Marina Quinlan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 18, 2016
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samplesRoddy Walsh, Kate L Thomson, James S Ware, et al.
Nature Communications|July 30, 2025
Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trialVivian Lee, Mayank Dalakoti, Qishi Zheng, et al.
Pageof 23